QuidelOrtho [QDEL] vs Stryker [SYK] Detailed Stock Comparison

QuidelOrtho

NASDAQ
Loading...

Stryker

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: QuidelOrtho wins in 7 metrics, Stryker wins in 11 metrics, with 0 ties. Stryker appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricQuidelOrthoStrykerBetter
P/E Ratio (TTM)-0.9249.84QuidelOrtho
Price-to-Book Ratio0.676.77QuidelOrtho
Debt-to-Equity Ratio100.3380.83Stryker
PEG Ratio-0.017.21QuidelOrtho
EV/EBITDA7.8224.76QuidelOrtho
Profit Margin (TTM)-17.01%12.25%Stryker
Operating Margin (TTM)-0.73%21.95%Stryker
EBITDA Margin (TTM)N/A21.95%N/A
Return on Equity-15.64%14.25%Stryker
Return on Assets (TTM)1.36%7.74%Stryker
Free Cash Flow (TTM)$-112.10M$3.49BStryker
Dividend YieldN/A0.88%N/A
1-Year Return-32.13%5.54%Stryker
Price-to-Sales Ratio (TTM)0.696.02QuidelOrtho
Enterprise Value$4.53B$158.14BStryker
EV/Revenue Ratio1.656.64QuidelOrtho
Gross Profit Margin (TTM)44.78%63.78%Stryker
Revenue per Share (TTM)$41$62Stryker
Earnings per Share (Diluted)$-6.84$7.53Stryker
Beta (Stock Volatility)0.270.95QuidelOrtho
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

QuidelOrtho vs Stryker Stock Performance Analysis

Loading Price Chart...

QuidelOrtho
Stryker
QuidelOrtho Stock Overview | Stryker Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
QuidelOrtho0.54%-10.85%-2.14%-9.60%6.34%-38.14%
Stryker1.64%3.06%-4.53%-3.65%11.24%4.62%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
QuidelOrtho-32.13%-63.48%-89.09%52.16%124.86%166.35%
Stryker5.54%79.45%67.50%275.18%665.27%707.77%

News Based Sentiment: QuidelOrtho vs Stryker

QuidelOrtho

News based Sentiment: MIXED

October presented a complex picture for QuidelOrtho, with positive industry tailwinds offset by analyst downgrades, increased debt costs, and concerns about revenue exposure to China. While the company is focused on improving efficiency and launching new products, the overall narrative is one of significant challenges and uncertainties, making it a mixed investment story.

View QuidelOrtho News Sentiment Analysis

Stryker

News based Sentiment: MIXED

October was a mixed month for Stryker, with strong financial results and strategic partnerships offset by stock price declines and insider selling. While the company reaffirmed its guidance and continues to invest in innovation, the conflicting signals suggest a cautious outlook for investors, making it a significant month to assess the company's trajectory.

View Stryker News Sentiment Analysis

Performance & Financial Health Analysis: QuidelOrtho vs Stryker

MetricQDELSYK
Market Information
Market Cap i$1.89B$143.48B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,487,8201,634,475
90 Day Avg. Volume i1,319,6701,322,345
Last Close$27.86$375.29
52 Week Range$22.05 - $49.45$329.16 - $406.19
% from 52W High-43.66%-7.61%
All-Time High$306.72 (Aug 03, 2020)$406.19 (Jan 27, 2025)
% from All-Time High-90.92%-7.61%
Growth Metrics
Quarterly Revenue Growth-0.04%0.11%
Quarterly Earnings Growth-0.04%0.07%
Financial Health
Profit Margin (TTM) i-0.17%0.12%
Operating Margin (TTM) i-0.01%0.22%
Return on Equity (TTM) i-0.16%0.14%
Debt to Equity (MRQ) i100.3380.83
Cash & Liquidity
Book Value per Share (MRQ)$41.25$55.43
Cash per Share (MRQ)$2.25$6.45
Operating Cash Flow (TTM) i$200.40M$4.77B
Levered Free Cash Flow (TTM) i$410.38M$3.49B
Dividends
Last 12-Month Dividend Yield iN/A0.88%
Last 12-Month Dividend iN/A$3.28

Valuation & Enterprise Metrics Analysis: QuidelOrtho vs Stryker

MetricQDELSYK
Price Ratios
P/E Ratio (TTM) i-0.9249.84
Forward P/E i10.4527.74
PEG Ratio i-0.017.21
Price to Sales (TTM) i0.696.02
Price to Book (MRQ) i0.676.77
Market Capitalization
Market Capitalization i$1.89B$143.48B
Enterprise Value i$4.53B$158.14B
Enterprise Value Metrics
Enterprise to Revenue i1.656.64
Enterprise to EBITDA i7.8224.76
Risk & Other Metrics
Beta i0.270.95
Book Value per Share (MRQ) i$41.25$55.43

Financial Statements Comparison: QuidelOrtho vs Stryker

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)QDELSYK
Revenue/Sales i$613.90M$6.02B
Cost of Goods Sold i$339.00M$2.18B
Gross Profit i$274.90M$3.84B
Research & Development i$45.70M$407.00M
Operating Income (EBIT) i$-1.80M$1.17B
EBITDA i$100.00M$1.52B
Pre-Tax Income i$-229.60M$1.02B
Income Tax i$25.80M$132.00M
Net Income (Profit) i$-255.40M$884.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)QDELSYK
Cash & Equivalents i$127.10M$2.32B
Total Current Assets i$1.26B$13.02B
Total Current Liabilities i$1.05B$7.93B
Long-Term Debt i$2.27B$14.38B
Total Shareholders Equity i$3.00B$20.93B
Retained Earnings i$123.10M$18.86B
Property, Plant & Equipment i$2.35B$1.67B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)QDELSYK
Operating Cash Flow i$41.90M$719.00M
Capital Expenditures i$-56.20M$-123.00M
Free Cash Flow i$9.40M$127.00M
Debt Repayment i$-36.00MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricQDELSYK
Shares Short i8.15M4.61M
Short Ratio i7.034.52
Short % of Float i0.20%0.01%
Average Daily Volume (10 Day) i1,487,8201,634,475
Average Daily Volume (90 Day) i1,319,6701,322,345
Shares Outstanding i67.26M381.40M
Float Shares i62.65M344.60M
% Held by Insiders i0.01%0.05%
% Held by Institutions i1.17%0.82%

Dividend Analysis & Yield Comparison: QuidelOrtho vs Stryker

MetricQDELSYK
Last 12-Month Dividend iN/A$3.28
Last 12-Month Dividend Yield iN/A0.88%
3-Year Avg Annual Dividend iN/A$3.09
3-Year Avg Dividend Yield iN/A0.27%
3-Year Total Dividends iN/A$9.26
Ex-Dividend DateN/AMar 31, 2025